Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland

Simon L, Vucinic V, Rejeski K, Schubert ML, Aydilek E, Wagner-Drouet EM, Penack O, von Bonin M, von Tresckow B, Teichert M, Marks R, Pott C, Fehr M, Leng C, Schroers R, Koenecke C, Duell J, Stilgenbauer S, Müller F, Hecker JS, Brunnberg U, Kroeger N, Kronfeld K, Theobald M, Ohler A, Schmidtmann I, Hess G, Dreger P (2026)


Publication Type: Journal article

Publication year: 2026

Journal

DOI: 10.1038/s41409-025-02789-7

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Simon, L., Vucinic, V., Rejeski, K., Schubert, M.L., Aydilek, E., Wagner-Drouet, E.M.,... Dreger, P. (2026). Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-025-02789-7

MLA:

Simon, Linda, et al. "Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland." Bone Marrow Transplantation (2026).

BibTeX: Download